
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Parkinson's Disease – the Debate on the Clinical Phenomenology, Aetiology, Pathology and Pathogenesis
Peter Jenner, Huw R. Morris, Trevor W. Robbins, et al.
Journal of Parkinson s Disease (2013) Vol. 3, Iss. 1, pp. 1-11
Open Access | Times Cited: 95
Peter Jenner, Huw R. Morris, Trevor W. Robbins, et al.
Journal of Parkinson s Disease (2013) Vol. 3, Iss. 1, pp. 1-11
Open Access | Times Cited: 95
Showing 1-25 of 95 citing articles:
Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein
Michel Goedert
Science (2015) Vol. 349, Iss. 6248
Closed Access | Times Cited: 868
Michel Goedert
Science (2015) Vol. 349, Iss. 6248
Closed Access | Times Cited: 868
The Synucleinopathies: Twenty Years On
Michel Goedert, Ross Jakes, Maria Grazia Spillantini
Journal of Parkinson s Disease (2017) Vol. 7, Iss. s1, pp. S51-S69
Open Access | Times Cited: 492
Michel Goedert, Ross Jakes, Maria Grazia Spillantini
Journal of Parkinson s Disease (2017) Vol. 7, Iss. s1, pp. S51-S69
Open Access | Times Cited: 492
Sex differences in Parkinson’s disease
Glenda E. Gillies, Ilse S. Pienaar, Shiv Vohra, et al.
Frontiers in Neuroendocrinology (2014) Vol. 35, Iss. 3, pp. 370-384
Open Access | Times Cited: 423
Glenda E. Gillies, Ilse S. Pienaar, Shiv Vohra, et al.
Frontiers in Neuroendocrinology (2014) Vol. 35, Iss. 3, pp. 370-384
Open Access | Times Cited: 423
Review: Sporadic Parkinson's disease: development and distribution of α‐synuclein pathology
Kelly Del Tredici, Heiko Braak
Neuropathology and Applied Neurobiology (2015) Vol. 42, Iss. 1, pp. 33-50
Closed Access | Times Cited: 344
Kelly Del Tredici, Heiko Braak
Neuropathology and Applied Neurobiology (2015) Vol. 42, Iss. 1, pp. 33-50
Closed Access | Times Cited: 344
Neuropathological Staging of Brain Pathology in Sporadic Parkinson’s disease: Separating the Wheat from the Chaff
Heiko Braak, Kelly Del Tredici
Journal of Parkinson s Disease (2017) Vol. 7, Iss. s1, pp. S71-S85
Open Access | Times Cited: 341
Heiko Braak, Kelly Del Tredici
Journal of Parkinson s Disease (2017) Vol. 7, Iss. s1, pp. S71-S85
Open Access | Times Cited: 341
Diagnostic Criteria for Parkinson’s Disease: From James Parkinson to the Concept of Prodromal Disease
Luca Marsili, Giovanni Rizzo, Carlo Colosimo
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 197
Luca Marsili, Giovanni Rizzo, Carlo Colosimo
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 197
Tau Pathology in Parkinson's Disease
Xue Zhang, Fei Gao, Dongdong Wang, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 162
Xue Zhang, Fei Gao, Dongdong Wang, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 162
LC–MS-Based Urinary Metabolite Signatures in Idiopathic Parkinson’s Disease
Hemi Luan, Liang‐Feng Liu, Nan Meng, et al.
Journal of Proteome Research (2014) Vol. 14, Iss. 1, pp. 467-478
Closed Access | Times Cited: 124
Hemi Luan, Liang‐Feng Liu, Nan Meng, et al.
Journal of Proteome Research (2014) Vol. 14, Iss. 1, pp. 467-478
Closed Access | Times Cited: 124
Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brain
Gerardo Leyva‐Gómez, Hernán Cortés, Jonathan J. Magaña, et al.
Drug Discovery Today (2015) Vol. 20, Iss. 7, pp. 824-837
Closed Access | Times Cited: 97
Gerardo Leyva‐Gómez, Hernán Cortés, Jonathan J. Magaña, et al.
Drug Discovery Today (2015) Vol. 20, Iss. 7, pp. 824-837
Closed Access | Times Cited: 97
The Cambridge Companion to Philosophical Methodology
Giuseppina D’Oro, Giuseppina D’Oro, Søren Overgaard, et al.
Cambridge University Press eBooks (2017)
Open Access | Times Cited: 97
Giuseppina D’Oro, Giuseppina D’Oro, Søren Overgaard, et al.
Cambridge University Press eBooks (2017)
Open Access | Times Cited: 97
Neurodegeneration and the ordered assembly of α-synuclein
Maria Grazia Spillantini, Michel Goedert
Cell and Tissue Research (2017) Vol. 373, Iss. 1, pp. 137-148
Open Access | Times Cited: 95
Maria Grazia Spillantini, Michel Goedert
Cell and Tissue Research (2017) Vol. 373, Iss. 1, pp. 137-148
Open Access | Times Cited: 95
Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling
Huiyuan Zhao, Cui Wang, Nan Zhao, et al.
Journal of Chromatography B (2018) Vol. 1081-1082, pp. 101-108
Open Access | Times Cited: 95
Huiyuan Zhao, Cui Wang, Nan Zhao, et al.
Journal of Chromatography B (2018) Vol. 1081-1082, pp. 101-108
Open Access | Times Cited: 95
Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice
Mattia Volta, Dayne Beccano-Kelly, Sarah A. Paschall, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 92
Mattia Volta, Dayne Beccano-Kelly, Sarah A. Paschall, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 92
Oxidative Stress and Neurodegeneration: Insights and Therapeutic Strategies for Parkinson’s Disease
Erjola Bej, Patrizia Cesare, Anna Rita Volpe, et al.
Neurology International (2024) Vol. 16, Iss. 3, pp. 502-517
Open Access | Times Cited: 14
Erjola Bej, Patrizia Cesare, Anna Rita Volpe, et al.
Neurology International (2024) Vol. 16, Iss. 3, pp. 502-517
Open Access | Times Cited: 14
What Can We Do, When We Do Metaphysics?
Amie L. Thomasson
Cambridge University Press eBooks (2017), pp. 101-121
Closed Access | Times Cited: 71
Amie L. Thomasson
Cambridge University Press eBooks (2017), pp. 101-121
Closed Access | Times Cited: 71
Lithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells
Begüm Alural, Ayşegül Özerdem, Jens Allmer, et al.
Frontiers in Cellular Neuroscience (2015) Vol. 9
Open Access | Times Cited: 69
Begüm Alural, Ayşegül Özerdem, Jens Allmer, et al.
Frontiers in Cellular Neuroscience (2015) Vol. 9
Open Access | Times Cited: 69
Mechanisms of alpha-synuclein toxicity: An update and outlook
Inês Caldeira Brás, Mary Xylaki, Tiago F. Outeiro
Progress in brain research (2019), pp. 91-129
Closed Access | Times Cited: 66
Inês Caldeira Brás, Mary Xylaki, Tiago F. Outeiro
Progress in brain research (2019), pp. 91-129
Closed Access | Times Cited: 66
Arylsulfatase A, a genetic modifier of Parkinson’s disease, is an α-synuclein chaperone
Jun Sung Lee, Kazuaki Kanai, Mari Suzuki, et al.
Brain (2019) Vol. 142, Iss. 9, pp. 2845-2859
Open Access | Times Cited: 55
Jun Sung Lee, Kazuaki Kanai, Mari Suzuki, et al.
Brain (2019) Vol. 142, Iss. 9, pp. 2845-2859
Open Access | Times Cited: 55
Tau Toxicity in Neurodegeneration
Shuyu Liang, Zuo-Teng Wang, Lan Tan, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 6, pp. 3617-3634
Closed Access | Times Cited: 35
Shuyu Liang, Zuo-Teng Wang, Lan Tan, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 6, pp. 3617-3634
Closed Access | Times Cited: 35
Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies
Yuho Okita, Alexandre Nay Rcom-H'cheo-Gauthier, Michael Goulding, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 60
Yuho Okita, Alexandre Nay Rcom-H'cheo-Gauthier, Michael Goulding, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 60
Multisystem Lewy body disease and the other parkinsonian disorders
J. William Langston, Birgitt Schüle, Linda Rees, et al.
Nature Genetics (2015) Vol. 47, Iss. 12, pp. 1378-1384
Closed Access | Times Cited: 59
J. William Langston, Birgitt Schüle, Linda Rees, et al.
Nature Genetics (2015) Vol. 47, Iss. 12, pp. 1378-1384
Closed Access | Times Cited: 59
Role of Ionizing Radiation in Neurodegenerative Diseases
Neel Sharma, Rupali Sharma, Deepali Mathur, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 58
Neel Sharma, Rupali Sharma, Deepali Mathur, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 58
Total and Proteinase K-Resistant α-Synuclein Levels in Erythrocytes, Determined by their Ability to Bind Phospholipids, Associate with Parkinson’s Disease
Suaad Abd-Elhadi, Asaf Honig, Dganit Simhi-Haham, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 47
Suaad Abd-Elhadi, Asaf Honig, Dganit Simhi-Haham, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 47
Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
Shengli Xu, Piu Chan
Biomolecules (2015) Vol. 5, Iss. 2, pp. 1122-1142
Open Access | Times Cited: 44
Shengli Xu, Piu Chan
Biomolecules (2015) Vol. 5, Iss. 2, pp. 1122-1142
Open Access | Times Cited: 44
Identification of Cognitive Training for Individuals with Parkinson’s Disease: A Systematic Review
Marina Francesca Gattoni, Silvia Gobbo, Sarah Feroldi, et al.
Brain Sciences (2025) Vol. 15, Iss. 1, pp. 61-61
Open Access
Marina Francesca Gattoni, Silvia Gobbo, Sarah Feroldi, et al.
Brain Sciences (2025) Vol. 15, Iss. 1, pp. 61-61
Open Access